Hypopigmentation Disorder Treatment Market Size, Share and Forecast

Posted by Aman Jaiswar on July 2nd, 2019

Transparency Market Research (TMR) has published a new report titled, “Hypopigmentation Disorder Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global hypopigmentation disorder treatment market was valued at US$ 1,277.7 Mn in 2017 and is projected to expand at a high CAGR of 5.9% from 2018 to 2026. Rise in prevalence of hypopigmentation disorders across the world is anticipated to drive the global hypopigmentation disorder treatment market during the forecast period.

Asia Pacific and North America are projected to dominate the global hypopigmentation disorder treatment market during the forecast period. The market in these regions is primarily driven by increase in government initiatives and awareness about vitiligo and other hypopigmentation disorders. The market in Asia Pacific is anticipated to expand at a high CAGR from 2018 to 2026. The hypopigmentation disorder treatment market in North America is expected to expand at a moderate CAGR during the forecast period. The hypopigmentation disorder treatment market in Latin America is likely to grow at a moderate pace from 2018 to 2026.

Request to View Sample of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=47592

In terms of treatment, the topical drugs segment is projected to account for dominant share of the global hypopigmentation disorder treatment market during the forecast period. The segment is anticipated to expand at a high CAGR from 2018 to 2026. Dominance of the segment is attributed to increase in patient preference for topical drugs as the first line of treatment due to lower cost and higher efficacy. The chemical peels segment held major share of the market in 2017, followed by the topical drugs segment, due to increase in acceptance and popularity of chemical peels by dermatologists as well as patients. The laser therapy and microdermabrasion segments accounted for around 10.0% share of the global hypopigmentation disorder treatment market in terms of revenue in 2017.

The report offers detailed segmentation of the global hypopigmentation disorder treatment market based on treatment, disease indication, and end-user. In terms of disease indication, the market has been classified into vitiligo, albinism, and others. The vitiligo segment is projected to account for leading share of the global market during the forecast period. Higher share of the segment is attributed to rise in the number of patients undergoing treatment for vitiligo. According to the Global Vitiligo Foundation, currently 70 million people across the world and about 2.7 million people in the U.S. have vitiligo.

Based on end-user, the aesthetic clinics & dermatology centers segment accounted for a leading share of the global hypopigmentation disorder treatment market in 2017. The segment is projected to gain market share from 2018 to 2026. The segment is anticipated to expand at a high CAGR during the forecast period due to the well-developed aesthetic clinic & dermatology center infrastructure, increase in adoption of new devices and techniques by aesthetic clinics & dermatology centers, and quality of expertise available in clinics. Hospitals was a prominent segment of the global market in 2017, followed by the aesthetic clinics & dermatology centers segment. This is due to increase in the number of multi-specialty hospitals in developing countries.